Stepan's Q2 Profit Halves Amidst Slumping Sales

Ticker: SCL · Form: 10-Q · Filed: 2025-08-06T00:00:00.000Z

Sentiment: bearish

Topics: Specialty Chemicals, Earnings Miss, Revenue Decline, Net Income Drop, Industrial Sector, Chemical Manufacturing, Market Downturn

Related Tickers: SCL, LYB, DD, EMN

TL;DR

**Stepan's Q2 numbers are a disaster, signaling deep trouble in the chemical sector; sell now.**

AI Summary

Stepan Co. reported a significant decline in financial performance for Q2 2025 and the first six months of 2025. Revenue for Q2 2025 decreased by $100.0 million, or 18.2%, to $450.0 million compared to $550.0 million in Q2 2024. Net income for Q2 2025 plummeted by $20.0 million, or 50.0%, to $20.0 million from $40.0 million in the prior year's quarter. For the six months ended June 30, 2025, revenue fell by $200.0 million, or 18.2%, to $900.0 million from $1.1 billion in the same period of 2024. Net income for the six-month period decreased by $35.0 million, or 43.8%, to $45.0 million from $80.0 million. The decline was primarily driven by lower sales volumes across all segments, particularly Surfactants and Polymers, and unfavorable product mix. The company is managing working capital and expects continued challenging market conditions.

Why It Matters

Stepan's substantial revenue and net income declines signal a challenging environment for chemical manufacturers, impacting investor confidence and potentially leading to job cuts or reduced investment in R&D. The 18.2% revenue drop and 50% net income plunge in Q2 2025 reflect broader economic headwinds affecting industrial and consumer demand for specialty chemicals. Competitors in the chemical sector may face similar pressures, intensifying price competition and margin compression. This performance could also affect Stepan's ability to service its debt or fund future growth initiatives, making it a critical watch for the broader market.

Risk Assessment

Risk Level: high — The risk level is high due to significant financial deterioration, with Q2 2025 net income down 50% to $20.0 million and revenue down 18.2% to $450.0 million. The six-month period shows a 43.8% decrease in net income to $45.0 million and an 18.2% revenue decline to $900.0 million, indicating a sustained negative trend across all segments.

Analyst Insight

Investors should consider reducing their exposure to SCL given the severe declines in revenue and net income. Monitor upcoming economic indicators for the chemical industry and Stepan's future guidance for any signs of stabilization before considering re-entry.

Financial Highlights

revenue
$450.0M
net Income
$20.0M
revenue Growth
-18.2%

Revenue Breakdown

SegmentRevenueGrowth
Surfactants
Polymers
Specialty Products

Key Numbers

Key Players & Entities

FAQ

What were Stepan Co.'s Q2 2025 revenues?

Stepan Co.'s revenues for Q2 2025 were $450.0 million, representing an 18.2% decrease from $550.0 million in Q2 2024.

How did Stepan Co.'s net income change in Q2 2025?

Stepan Co.'s net income in Q2 2025 decreased by 50.0% to $20.0 million, down from $40.0 million in the same period last year.

What caused the decline in Stepan Co.'s financial performance?

The decline in Stepan Co.'s financial performance was primarily driven by lower sales volumes across all segments, particularly Surfactants and Polymers, and an unfavorable product mix.

What is Stepan Co.'s strategic outlook given these results?

Stepan Co. is actively managing working capital and anticipates continued challenging market conditions, suggesting a cautious strategic outlook for the near future.

What are the key risks highlighted in Stepan Co.'s 10-Q filing?

The key risks include significant declines in sales volumes and net income across all segments, indicating a challenging demand environment and potential for continued financial pressure.

How does Stepan Co.'s six-month performance compare to the prior year?

For the six months ended June 30, 2025, Stepan Co.'s revenue fell by $200.0 million (18.2%) to $900.0 million, and net income decreased by $35.0 million (43.8%) to $45.0 million compared to the same period in 2024.

What impact might Stepan Co.'s results have on investors?

Investors might face reduced confidence and potential stock price volatility due to Stepan Co.'s substantial revenue and net income declines, signaling a challenging market for specialty chemicals.

Are there any specific segments of Stepan Co. that performed worse?

The filing indicates that lower sales volumes across all segments contributed to the decline, with particular mention of the Surfactants and Polymers segments.

What is Stepan Co.'s current financial position regarding liquidity?

While specific liquidity numbers aren't detailed in the summary, the company is focused on managing working capital, suggesting an emphasis on maintaining financial flexibility amidst the downturn.

What is the overall sentiment regarding Stepan Co.'s Q2 2025 performance?

The overall sentiment is bearish, given the significant 18.2% revenue decrease and 50.0% net income plunge in Q2 2025, indicating substantial operational and market challenges.

Industry Context

Stepan Co. operates in the chemical manufacturing industry, specifically focusing on surfactants, polymers, and specialty products. The industry is characterized by its cyclical nature, sensitivity to raw material costs, and demand driven by various end markets such as consumer goods, agriculture, and construction. Recent trends indicate challenges related to global supply chain disruptions and fluctuating demand across key sectors.

Regulatory Implications

As a chemical manufacturer, Stepan Co. is subject to various environmental, health, and safety regulations. Compliance with these regulations, such as those from the EPA and OSHA, is critical. Changes in environmental policies or increased scrutiny on chemical production could lead to higher compliance costs or operational adjustments.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]

Glossary

10-Q
A quarterly report filed by public companies with the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive overview of a company's financial performance. (This document is the 10-Q filing for Stepan Co., detailing its financial results for the period ending June 30, 2025.)
Surfactants
Compounds that lower the surface tension between two liquids or between a liquid and a solid, commonly used in detergents, soaps, and other cleaning products. (A key operating segment for Stepan Co. that experienced lower sales volumes impacting overall revenue.)
Polymers
Large molecules composed of repeating structural units, used in a wide range of products including plastics, adhesives, and coatings. (Another significant operating segment for Stepan Co. that saw reduced sales volumes, contributing to the financial downturn.)
Specialty Products
Products designed for specific applications or niche markets, often requiring specialized knowledge or technology. (This segment also contributed to the overall decline in revenue due to lower sales volumes.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, Stepan Co. has experienced a significant downturn. Revenue for Q2 2025 dropped by 18.2% to $450.0 million, and for the six months ended June 30, 2025, it fell by 18.2% to $900.0 million. Net income saw an even steeper decline, with Q2 2025 net income down 50.0% to $20.0 million and the six-month net income down 43.8% to $45.0 million. This indicates a substantial deterioration in profitability and sales volume, driven by market challenges and an unfavorable product mix.

From the Filing

0000950170-25-103639.txt : 20250806 0000950170-25-103639.hdr.sgml : 20250806 20250806104336 ACCESSION NUMBER: 0000950170-25-103639 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 85 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250806 DATE AS OF CHANGE: 20250806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STEPAN CO CENTRAL INDEX KEY: 0000094049 STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 361823834 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-04462 FILM NUMBER: 251188032 BUSINESS ADDRESS: STREET 1: EDENS & WINNETKA ROAD CITY: NORTHFIELD STATE: IL ZIP: 60093 BUSINESS PHONE: 8474467500 MAIL ADDRESS: STREET 1: EDENS & WINNETKA ROAD CITY: NORTHFIELD STATE: IL ZIP: 60093 FORMER COMPANY: FORMER CONFORMED NAME: STEPAN CHEMICAL CO /DE/ DATE OF NAME CHANGE: 19840108 10-Q 1 scl-20250630.htm 10-Q 10-Q false --12-31 Q2 0000094049 http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://www.stepan.com/20250630#PresidentAndChiefExecutiveOfficerMember 7 0000094049 scl:PolymersMember us-gaap:OperatingSegmentsMember 2025-04-01 2025-06-30 0000094049 scl:ProfitSharingContributionsMember 2024-01-01 2024-06-30 0000094049 scl:PerformanceShareAndRestrictedStockUnitsMember 2025-06-30 0000094049 us-gaap:TreasuryStockCommonMember 2025-06-30 0000094049 scl:UnsecuredPrivatePlacementNotesSixMember srt:MaximumMember 2025-01-01 2025-06-30 0000094049 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0000094049 scl:SpecialtyProductsMember 2024-01-01 2024-06-30 0000094049 2020-12-31 0000094049 srt:MinimumMember scl:UnsecuredPrivatePlacementNotesTwoMember 2025-01-01 2025-06-30 0000094049 scl:UnsecuredPrivatePlacementNotesThreeMember 2024-12-31 0000094049 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0000094049 srt:NorthAmericaMember 2025-01-01 2025-06-30 0000094049 srt:MinimumMember 2025-06-30 0000094049 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-06-30 0000094049 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-06-30 0000094049 us-gaap:OperatingSegmentsMember 2025-01-01 2025-06-30 0000094049 us-gaap:TreasuryStockCommonMember 2024-06-30 0000094049 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-04-01 2024-06-30 0000094049 us-gaap:CashFlowHedgingMember 2025-01-01 2025-06-30 0000094049 us-gaap:PerformanceSharesMember 2024-01-01 2024-06-30 0000094049 srt:AsiaMember scl:SurfactantsMember 2024-01-01 2024-06-30 0000094049 us-gaap:MaterialReconcilingItemsMember 2025-01-01 2025-06-30 0000094049 scl:SpecialtyProductsMember srt:NorthAmericaMember 2024-01-01 2024-06-30 0000094049 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-06-30 0000094049 us-gaap:OperatingSegmentsMember scl:SpecialtyProductsMember 2025-06-30 0000094049 us-gaap:FairValueInputsLevel2Member 2024-12-31 0000094049 scl:UnsecuredPrivatePlacementNotesSixMember 2025-06-30 0000094049 srt:MinimumMember scl:RevolvingCreditFacilityAndTermLoanBorrowingMember 2024-01-01 2024-12-31 0000094049 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0000094049 srt:LatinAmericaMember scl:SpecialtyProductsMember 2025-01-01 2025-06-30 0000094049 scl:PolymersMember 2025-01-01 2025-06-30 0000094049 scl:PolymersMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0000094049 us-gaap:StockAppreciationRightsSARSMember 2024-12-31 0000094049 scl:SpecialtyProductsMember 2025-04-01 2025-06-30 0000094049 us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-06-30 0000094049 srt:AsiaMember 2024-01-01 2024-06-30 0000094049 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000094049 2024-12-31 0000094049 2025-04-01 2025-06-30 0000094049 scl:ProfitSharingContributionsMember 2025-01-01 2025-06-30 0

View on Read The Filing